TP53 and cancer: Bioinformatics analyses and data mining suggest that PCC has promising applications in cancer by affecting the activity and expression of HSP90AA1, subsequently interacting with TP53, EGFR, and ESR1 (client proteins of HSP90AA1), triggering a cascade reaction.